(2023). Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis. Health Technol Assess, 27, 1-140. http://doi.org/10.3310/ctmd0148.
(2023). Frequency and impact of medication reviews for people aged 65 years or above in UK primary care: an observational study using electronic health records. Bmc Geriatr, 23, 435. http://doi.org/10.1186/s12877-023-04143-2.
(2022). Cardiovascular outcomes and mortality after incident ischaemic stroke in patients with a recent cancer history. Eur J Intern Med. http://doi.org/10.1016/j.ejim.2022.12.006.
(2022). Comparison of risk of serious cardiovascular events after haemorrhagic versus ischaemic stroke: a population-based study. Thromb Haemost. http://doi.org/10.1055/a-1873-9092.
(2022). Ethnic disparities in mortality among overweight or obese adults with newly diagnosed type 2 diabetes: a population-based cohort study. J Endocrinol Invest. http://doi.org/10.1007/s40618-021-01736-9.
(2019). Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease. Heart. http://doi.org/10.1136/heartjnl-2018-314253.
(2021). Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care. Open Heart. http://doi.org/10.1136/openhrt-2021-001817.
(2021). Obesity and long-term outcomes after incident stroke: a prospective population-based cohort study. J Cachexia Sarcopenia Muscle. http://doi.org/10.1002/jcsm.12818.
(2021). Determining propensity for sub-optimal low-density lipoprotein cholesterol response to statins and future risk of cardiovascular disease. PLoS One. http://doi.org/10.1371/journal.pone.0260839.